Ticker League

Operating Margin for Regeneron Pharmaceuticals (REGN)

As of · Reported

Metric

TTM

24.3%

YoY change

−3.15pp

Trough year (2002)

-554.6%

Peak year (2021)

55.7%

Operating Margin history chart for Regeneron Pharmaceuticals (REGN) from 1990 to 2025

Latest: 24.9%

Operating Margin change chart for Regeneron Pharmaceuticals (REGN) from 1990 to 2025

Latest: −3.15pp

Operating Margin history table for Regeneron Pharmaceuticals (REGN) from 1990 to 2025

  • 202524.9%-3.15pp
  • 202428.1%-5.05pp
  • 202333.2%-11.09pp
  • 202244.2%-11.43pp
  • 202155.7%+13.58pp
  • 202042.1%+8.39pp
  • 201933.7%-4.07pp
  • 201837.8%+2.35pp
  • 201735.4%+8.03pp
  • 201627.4%-3.13pp
  • 201530.5%+1.29pp
  • 201429.2%-6.08pp
  • 201335.3%+1.90pp
  • 201233.4%+79.43pp
  • 2011-46.0%-24.79pp
  • 2010-21.2%-1.69pp
  • 2009-19.5%+18.13pp
  • 2008-37.7%+53.87pp
  • 2007-91.5%+77.58pp
  • 2006-169.1%+18.84pp
  • 2005-188.0%-191.21pp
  • 20043.2%+177.15pp
  • 2003-173.9%+380.73pp
  • 2002-554.6%-164.69pp
  • 2001-389.9%-347.31pp
  • 2000-42.6%+26.34pp
  • 1999-69.0%-36.26pp
  • 1998-32.7%-10.06pp
  • 1997-22.7%+49.13pp
  • 1996-71.8%-44.05pp
  • 1995-27.7%+98.12pp
  • 1994-125.9%+240.18pp
  • 1993-366.0%-206.91pp
  • 1992-159.1%-27.62pp
  • 1991-131.5%-65.51pp
  • 1990-66.0%—

Operating Margin values are taken from Regeneron Pharmaceuticals's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Operating Margin at Regeneron Pharmaceuticals (REGN)

According to Regeneron Pharmaceuticals's latest reported financial statements, the company's latest reported operating margin is 24.3%. Operating margin is operating income divided by revenue — the share of each sales dollar left after cost of goods sold and operating expenses (SG&A, R&D), but before interest and taxes. It isolates how profitable the core business is before financing and tax decisions, so it is comparable across companies with different capital structures.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

2025's annual operating margin for Regeneron Pharmaceuticals (REGN) came in at 24.95% – contracted 3.2 percentage points year-over-year.

The record annual operating margin stands at 55.67%, reached in 2021; the historical low of -554.63% was recorded in 2002.

Regeneron Pharmaceuticals Operating Margin by Year

Regeneron Pharmaceuticals Operating Margin 2025: 24.9%

Regeneron Pharmaceuticals operating margin in 2025 was 24.95%, contracted 3.2 percentage points from 2024.

Regeneron Pharmaceuticals Operating Margin 2024: 28.1%

2024's operating margin for Regeneron Pharmaceuticals came in at 28.10%, contracted 5.1 percentage points from 2023.

Regeneron Pharmaceuticals Operating Margin 2023: 33.2%

Regeneron Pharmaceuticals posted operating margin of 33.15% in 2023, contracted 11.1 percentage points from 2022.

Regeneron Pharmaceuticals Operating Margin 2022: 44.2%

In 2022, Regeneron Pharmaceuticals reported operating margin of 44.24%, contracted 11.4 percentage points from 2021.

Regeneron Pharmaceuticals Operating Margin 2021: 55.7%

Regeneron Pharmaceuticals operating margin in 2021 was 55.67%.

See more financial history for Regeneron Pharmaceuticals (REGN).

Sector peers by Operating Margin

Healthcare peers of Regeneron Pharmaceuticals (REGN), ranked by their latest operating margin

Frequently asked questions

Regeneron Pharmaceuticals (REGN) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation